Search Top Featured Websites...
Share your business, services, products, events & news. Get added to TopFeatured.com. DETAILS.
Breaking Top Featured Content:
Share your business, services, products, events & news. Get added to TopFeatured.com. DETAILS.
Breaking Top Featured Content:
Drug reduces risk of relapse with neuromyelitis optica
The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). This rare but severe autoimmune inflammatory disorder can cause blindness, paralysis and death.
Press Release Distribution Service
